It was shown that treatment of mice with anti-PD-L1 therapy combined with YKL-40 knockout achieved significant inhibition of tumor growth compared to the separate use of anti-PD-L1 antibodies and YKL-40 knockout. This evidence concerns the gene CD274 and neoplasm.